Developing bioprosthetic devices for cardiovascular surgeries.
Industry: Health Care
First Day Return: +4.8%
IPO Data | |
---|---|
IPO Date | 05/30/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $8 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Irvine, CA, United States |
Founded | 1999 |
Employees at IPO | 9 |
Website www.hancockjaffe.com |